205 related articles for article (PubMed ID: 17434095)
1. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study.
Wong KS; Chen C; Ng PW; Tsoi TH; Li HL; Fong WC; Yeung J; Wong CK; Yip KK; Gao H; Wong HB;
Lancet Neurol; 2007 May; 6(5):407-13. PubMed ID: 17434095
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin and early neurologic deterioration in acute stroke caused by large artery occlusive disease.
Wang Q; Chen C; Chen XY; Han JH; Soo Y; Leung TW; Mok V; Wong KS
Arch Neurol; 2012 Nov; 69(11):1454-60. PubMed ID: 22893265
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: subgroup analyses from the Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study.
Wang QS; Chen C; Chen XY; Han JH; Soo Y; Leung TW; Mok V; Wong KS
Stroke; 2012 Feb; 43(2):346-9. PubMed ID: 22076004
[TBL] [Abstract][Full Text] [Related]
4. Nadroparin plus aspirin versus aspirin alone in the treatment of acute ischemic stroke.
Sarma GR; Roy AK
Neurol India; 2003 Jun; 51(2):208-10. PubMed ID: 14571005
[TBL] [Abstract][Full Text] [Related]
5. Low-Molecular-Weight Heparin Versus Aspirin in Early Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Xia H; Wang Z; Tian M; Liu Z; Zhou Z
Front Immunol; 2022; 13():823391. PubMed ID: 35281068
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin is more effective than aspirin in preventing early neurologic deterioration and improving six-month outcome.
Yi X; Lin J; Wang C; Zhang B; Chi W
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1537-44. PubMed ID: 24656240
[TBL] [Abstract][Full Text] [Related]
7. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial.
Berge E; Abdelnoor M; Nakstad PH; Sandset PM
Lancet; 2000 Apr; 355(9211):1205-10. PubMed ID: 10770301
[TBL] [Abstract][Full Text] [Related]
8. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.
Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558
[TBL] [Abstract][Full Text] [Related]
9. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
Belcaro G; Nicolaides AN; Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Barsotti A; Corsi M; Vasdekis S; Christopoulos D; Lennox A; Malouf M
Angiology; 1999 Oct; 50(10):781-7. PubMed ID: 10535716
[TBL] [Abstract][Full Text] [Related]
10. Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis.
López-Beret P; Orgaz A; Fontcuberta J; Doblas M; Martinez A; Lozano G; Romero A
J Vasc Surg; 2001 Jan; 33(1):77-90. PubMed ID: 11137927
[TBL] [Abstract][Full Text] [Related]
11. The safety and efficacy of Heparin and Nadroparin compared to placebo in acute ischemic stroke - pilot study.
Dluha J; Sivak S; Kurca E; Dusenka R; Kalmarova K; Turcanova Koprusakova M; Kantorova E; Nosal V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):543-548. PubMed ID: 27646496
[TBL] [Abstract][Full Text] [Related]
12. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.
Wong KS; Chen C; Fu J; Chang HM; Suwanwela NC; Huang YN; Han Z; Tan KS; Ratanakorn D; Chollate P; Zhao Y; Koh A; Hao Q; Markus HS;
Lancet Neurol; 2010 May; 9(5):489-97. PubMed ID: 20335070
[TBL] [Abstract][Full Text] [Related]
13. Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial.
Kim BJ; Lee EJ; Kwon SU; Park JH; Kim YJ; Hong KS; Wong LKS; Yu S; Hwang YH; Lee JS; Lee J; Rha JH; Heo SH; Ahn SH; Seo WK; Park JM; Lee JH; Kwon JH; Sohn SI; Jung JM; Navarro JC; Kang DW;
Lancet Neurol; 2018 Jun; 17(6):509-518. PubMed ID: 29778364
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome).
Eur Heart J; 1999 Nov; 20(21):1553-62. PubMed ID: 10529323
[TBL] [Abstract][Full Text] [Related]
15. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A
Angiology; 2007; 58(3):316-22. PubMed ID: 17626986
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight heparin significantly reduces embolisation after carotid endarterectomy--a randomised controlled trial.
McMahon GS; Webster SE; Hayes PD; Jones CI; Goodall AH; Naylor AR
Eur J Vasc Endovasc Surg; 2009 Jun; 37(6):633-9. PubMed ID: 19328023
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis.
Lopaciuk S; Bielska-Falda H; Noszczyk W; Bielawiec M; Witkiewicz W; Filipecki S; Michalak J; Ciesielski L; Mackiewicz Z; Czestochowska E; Zawilska K; Cencora A
Thromb Haemost; 1999 Jan; 81(1):26-31. PubMed ID: 9974369
[TBL] [Abstract][Full Text] [Related]
18. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Kaandorp SP; Goddijn M; van der Post JA; Hutten BA; Verhoeve HR; Hamulyák K; Mol BW; Folkeringa N; Nahuis M; Papatsonis DN; Büller HR; van der Veen F; Middeldorp S
N Engl J Med; 2010 Apr; 362(17):1586-96. PubMed ID: 20335572
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial.
Righini M; Galanaud JP; Guenneguez H; Brisot D; Diard A; Faisse P; Barrellier MT; Hamel-Desnos C; Jurus C; Pichot O; Martin M; Mazzolai L; Choquenet C; Accassat S; Robert-Ebadi H; Carrier M; Le Gal G; Mermilllod B; Laroche JP; Bounameaux H; Perrier A; Kahn SR; Quere I
Lancet Haematol; 2016 Dec; 3(12):e556-e562. PubMed ID: 27836513
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial.
van der Steen W; van de Graaf RA; Chalos V; Lingsma HF; van Doormaal PJ; Coutinho JM; Emmer BJ; de Ridder I; van Zwam W; van der Worp HB; van der Schaaf I; Gons RAR; Yo LSF; Boiten J; van den Wijngaard I; Hofmeijer J; Martens J; Schonewille W; Vos JA; Tuladhar AM; de Laat KF; van Hasselt B; Remmers M; Vos D; Rozeman A; Elgersma O; Uyttenboogaart M; Bokkers RPH; van Tuijl J; Boukrab I; van den Berg R; Beenen LFM; Roosendaal SD; Postma AA; Krietemeijer M; Lycklama G; Meijer FJA; Hammer S; van der Hoorn A; Yoo AJ; Gerrits D; Truijman MTB; Zinkstok S; Koudstaal PJ; Manschot S; Kerkhoff H; Nieboer D; Berkhemer O; Wolff L; van der Sluijs PM; van Voorst H; Tolhuisen M; Roos YBWEM; Majoie CBLM; Staals J; van Oostenbrugge RJ; Jenniskens SFM; van Dijk LC; den Hertog HM; van Es ACGM; van der Lugt A; Dippel DWJ; Roozenbeek B;
Lancet; 2022 Mar; 399(10329):1059-1069. PubMed ID: 35240044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
